Northern Trust Corp Nautilus Biotechnology, Inc. Transaction History

Northern Trust Corp

$572 Billion
Q1 2024

A detailed history of Northern Trust Corp transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 514,276 shares of NAUT stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

514,276

Previous 533,817 3.66%

Holding current value

$1.17 Million

Previous $1.6 Million 5.33%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$2.41 - $3.18 $47,093 - $62,140	-19,541 Reduced 3.66%	514,276 $1.51 Million
Q4 2023 Feb 13, 2024	SELL	$2.34 - $3.39 $1,172 - $1,698	-501 Reduced 0.09%	533,817 $1.6 Million
Q3 2023 Nov 13, 2023	SELL	$2.87 - $3.94 $2,723 - $3,739	-949 Reduced 0.18%	534,318 $1.69 Million
Q2 2023 Aug 11, 2023	BUY	$2.21 - $4.52 $199,346 - $407,713	90,202 Added 20.27%	535,267 $2.07 Million
Q1 2023 May 15, 2023	BUY	$1.67 - $2.77 $2,463 - $4,085	1,475 Added 0.33%	445,065 $1.23 Million

Q4 2022 Feb 13, 2023	SELL	$1.55 - $2.47 $2,765 - $4,406	-1,784 Reduced 0.4%	443,590 $798,000
Q3 2022 Nov 14, 2022	SELL	$1.96 - $3.13 $8,279 - $13,221	-4,224 Reduced 0.94%	445,374 $945,000
Q2 2022 Aug 12, 2022	BUY	$2.64 - $4.84 $816,483 - $1.5 Million	309,274 Added 220.4%	449,598 $1.21 Million
Q1 2022 May 13, 2022	SELL	$3.5 - $5.3 $14,080 - $21,321	-4,023 Reduced 2.79%	140,324 $609,000
Q4 2021 Feb 08, 2022	BUY	$4.45 - $6.21 $239,245 - $333,868	53,763 Added 59.35%	144,347 $748,000
Q3 2021 Nov 15, 2021	BUY	$6.14 - $10.1 $556,185 - $914,898	90,584 New	90,584 $556,000

Others Institutions Holding NAUT

# of Institutions

Shares Held

63.1M

Call Options Held

14K

Put Options Held

1.8K

View Full List

About Nautilus Biotechnology, Inc.

Ticker NAUT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,663,000
Market Cap $283M
Description
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...

More about NAUT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Nautilus Biotechnology, Inc. Transaction History